ANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-appoints-gerardo-hernandez-as-chief-financial-officer-and-provides-updated-2024-financial-outlook-302320060.html SOURCE TransMedics Group, Inc.Hezbollah Bombards Haifa; Israelis Flee Homes | Huge Attack Near Beirut Airport Ahead Of TruceTesco worker's 11 things they wish they could share with customers
If there's one thing you should know about me, it's that I am a creature of habit. In 2020 and the four years prior, I had a standing Brazilian appointment at European Wax Center and you could find me there, like clockwork, every four weeks. I was always told that, no matter what, I shouldn't try shaving in between waxes because it would make the next session more painful. When my city closed all nonessential businesses at the start of the pandemic, I held out for a little over a month before coming to the realization that I was going to have to shave . I had always dutifully listened to my aesthetician's advice, but I was at the point where I couldn't take it much longer. My first attempt at shaving went terribly. I was not prepared for how spiky and sharp my hair would feel post-shave, the nicks and cuts, or the feeling that with one wrong move I would suffer from severe rug burn due to my vagina stubble. Also, I wasn't even going to attempt shaving the hair back there . Putting a razor in an area I could barely see without a mirror? No, thank you. Swearing off shaving for good left me with two choices: grow out a full bush or learn how to DIY a Brazilian wax. Thinking back to everything I knew about DIY waxing , one anecdote stuck in my mind. During one of my past waxing appointments, in an effort to make the waxing experience a little less awkward, I asked my aesthetician if she got waxed or waxed herself. "Don't ever try waxing yourself," she told me sternly. "One time a girl came in here after trying that, but the wax had dried on her hair because she was too scared to pull it off. She was lucky we were able to get it off. She was about 30 minutes away from having to go to the hospital." This story ran through my head every time I considered giving myself an at-home wax. I knew I was brave, but just how brave? Was I "rip my pubic hair off with hot wax" brave? I wasn't sure. With that thought in mind, I realized I needed backup. I considered my options. I could call my mother, but she couldn't do much more than cheer me on through FaceTime. Could I ask a friend who lived down the street? My cousin? The answer sat there on the couch next to me, watching "Homeland." My boyfriend. Yes, he would be the one to go into battle with me. We could do this together. "Would you be willing to give me a Brazilian wax?" I asked him. "Sure," he said noncommittally. My eyes lit up as the wheels in my brain started turning. A few days later when I brought up his everlasting love for me and his commitment to help me wax my nether regions, he was still game. I already owned the Bliss Poetic Waxing Hair Removal Kit ($13) that had great reviews online. One of my coworkers had even tried it herself and noted that it was one of the less painful kits she had tried, albeit messy. There were a few things I opted not to tell my boyfriend prior to beginning our waxing experience together. The first was that my aesthetician had given me the nickname "The Flincher" because every time she applied hot wax I would flinch. I figured my boyfriend would figure this out on his own. The second was that I was on my period. I had been waxed plenty of times while on my period, and I did what I normally did — showered and made sure I had a fresh tampon in. Again, I filed this under the "things my boyfriend would soon find out" category. Prior to beginning, I read the wax kit's instructions in their entirety, and decided my boyfriend should hear them as well. As I sat there explaining the laundry list of tips to him, I could see everything going in one ear and out the other as his eyes glazed over. Figuring our best bet was just to dive right in, I shut up and decided to get to it. The first thing we did was set up our space. I looked around for an area I could lay on that was about the height of a massage table, and my eyes landed on our kitchen counter. Not the most sanitary, but desperate times call for desperate measures. I laid two bath towels down and brought my full-length mirror into the kitchen, where I set it against the fridge. Just because I was willing to let a licensed aesthetician do her magic with my eyes closed, did not mean my boyfriend was going down there unsupervised with hot wax in hand. The waxing kit we used needed to be heated up in the microwave in 30 second intervals, which felt like a lifetime. Both of us were nervous, and by the time we hit our fifth minute, I was worried my boyfriend was going to lock himself in a bathroom and refuse to come out. Finally, after the sixth minute, the wax seemed hot enough to apply. I hopped up on the kitchen counter and butterflied my legs. At this point in time, my confidence was beginning to sway, and I could feel myself starting to sweat. Who did I think I was? The girl who hopped on the kitchen island 10 seconds ago and butterflied her legs without a care in the world was not the same girl staring at me in the mirror. I was not a professional, and neither was my boyfriend. Since I had a little more experience, I decided to attempt it on my own at first. I took deep breaths and tried to calm myself down. I mixed the wax and began spreading it over a patch of hair. My boyfriend came over and held my back so I could relax against his arms while I pulled the first strip. When it came time to do the actual pulling, I was a mess. My hands were sweating and my brain was melting at the thought of ripping this hair out. Seeing my hesitation, my boyfriend tried cheering me on: "Just rip it like a Band-Aid!" When that didn't work, he decided it was time to take the reins. He told me to lay back and get comfortable, and he got to work. As you can imagine, the first few strips were shocking, but eventually we got into a rhythm. We got through the rest of the waxing fairly painlessly (OK, as "painless" as a Brazilian wax done by someone who has never done it before can get), with my boyfriend stopping occasionally to ask questions. He quickly adopted the motto of "scoop and spread" when applying the wax, as well as "breathe in, breathe out" when pulling strips of wax. Toward the end, I was actually starting to feel like I was in a salon. A very inexpensive, not totally sanitary, and unlicensed salon. Overall, while I did find myself stressed out for much of the experience, I also found myself laughing 99 percent of the time. I am truly proud of the fact that my boyfriend was able to handle this task in stride with a very minimal amount of complaining. We've since broken up, (unrelated to the waxing, I swear) and although I was pulling wax off of my butt in the shower for two days afterward, I would probably do it again. Also, the kit was only $23, and my boyfriend's labor was free, so cheers to that! Renee Rodriguez (she/her) is a staff writer and social producer for PS. She writes across all verticals, but her main areas of expertise focus on fashion and beauty content with an emphasis on reviews and editor experiments. She also produces social content for the PS TikTok and Instagram accounts.Oracle misses quarterly results estimates on stiff cloud competition
NEW YORK (AP) — U.S. stock indexes got back to climbing on Wednesday after the latest update on inflation appeared to clear the way for more help for the economy from the Federal Reserve . The S&P 500 rose 0.8% to break its first two-day losing streak in nearly a month and finished just short of its all-time high. Big Tech stocks led the way, which drove the Nasdaq composite up 1.8% to top the 20,000 level for the first time. The Dow Jones Industrial Average, meanwhile, lagged the market with a dip of 99 points, or 0.2%. Stocks got a boost as expectations built that Wednesday’s inflation data will allow the Fed to deliver another cut to interest rates at its meeting next week. Traders are betting on a nearly 99% probability of that, according to data from CME Group, up from 89% a day before. If they’re correct, it would be a third straight cut by the Fed after it began lowering rates in September from a two-decade high. It’s hoping to support a slowing job market after getting inflation nearly all the way down to its 2% target. Lower rates would give a boost to the economy and to prices for investments, but they could also provide more fuel for inflation. “The data have given the Fed the ‘all clear’ for next week, and today’s inflation data keep a January cut in active discussion,” according to Ellen Zentner, chief economic strategist for Morgan Stanley Wealth Management. Expectations for a series of cuts to rates by the Fed have been one of the main reasons the S&P 500 has set an all-time high 57 times this year , with the latest coming last week. The biggest boosts for the index on Wednesday came from Nvidia and other Big Tech stocks. Their massive growth has made them Wall Street’s biggest stars for years, though other kinds of stocks have recently been catching up somewhat amid hopes for the broader U.S. economy. Tesla jumped 5.9% to finish above $420 at $424.77. It’s a level that Elon Musk made famous in a 2018 tweet when he said he had secured funding to take Tesla private at $420 per share . Stitch Fix soared 44.3% after the company that sends clothes to your door reported a smaller loss for the latest quarter than analysts expected. It also gave financial forecasts for the current quarter that were better than expected, including for revenue. GE Vernova rallied 5% for one of the biggest gains in the S&P 500. The energy company that spun out of General Electric said it would pay a 25 cent dividend every three months, and it approved a plan to send up to another $6 billion to its shareholders by buying back its own stock. On the losing end of Wall Street, Dave & Buster’s Entertainment tumbled 20.1% after reporting a worse loss for the latest quarter than expected. It also said CEO Chris Morris has resigned, and the board has been working with an executive-search firm for the last few months to find its next permanent leader. Albertsons fell 1.5% after filing a lawsuit against Kroger, saying it didn’t do enough for their proposed $24.6 billion merger agreement to win regulatory clearance. Albertsons said it’s seeking billions of dollars in damages from Kroger, whose stock rose 1%. A day earlier, judges in separate cases in Oregon and Washington nixed the supermarket giants’ merger. The grocers contended a combination could have helped them compete with big retailers like Walmart, Costco and Amazon, but critics said it would hurt competition. After terminating the merger agreement with Kroger, Albertsons said it plans to boost its dividend 25% and increased the size of its program to buy back its own stock. Macy’s slipped 0.8% after cutting some of its financial forecasts for the full year of 2024, including for how much profit it expects to make off each $1 of revenue. All told, the S&P 500 rose 49.28 points to 6,084.19. The Dow dipped 99.27 to 44,148.56, and the Nasdaq composite rallied 347.65 to 20,034.89. In the bond market, the yield on the 10-year Treasury rose to 4.27% from 4.23% late Tuesday. The two-year Treasury yield, which more closely tracks expectations for the Fed, edged up to 4.15% from 4.14%. In stock markets abroad, indexes rose across much of Europe and Asia. Hong Kong’s Hang Seng was an outlier and slipped 0.8% as Chinese leaders convened an annual planning meeting in Beijing that is expected to set economic policies and growth targets for the coming year. South Korea’s Kospi rose 1%, up for a second straight day as it climbs back following last week’s political turmoil where its president briefly declared martial law. AP Writers Matt Ott and Zimo Zhong contributed.On a per-share basis, the New York-based company said it had a loss of 10 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to 12 cents per share. The software developer posted revenue of $114 million in the period. Yext expects full-year revenue in the range of $420.3 million to $420.8 million. This story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on YEXT at https://www.zacks.com/ap/YEXT
Clay's 15 help Morehead State take down Alice Lloyd 94-63
None
NoneCasino Gaming Market to Grow by USD 43.3 Billion (2024-2028), Rising Customer Spending Boosts Growth, AI Driving Market Transformation - TechnavioNone
Week 12 TNF: Steelers-Browns Preview, Props & Prediction
OptiSigns to Showcase Cutting-Edge Digital Signage Solutions at the Digital Signage Experience 2024 in Las VegasAnalysis: Barkley is NFL's version of Ohtani
National Food Authority (NFA) Administrator Larry Lacson assured the public that the agency is prepared to release NFA rice to relief-giving institutions during emergencies and calamities, including during the holiday season. Lacson made this statement in response to reports on the activity of Bulkang Kanlaon and the monitored forecasts on the intertropical convergence zone and rain showers affecting most parts of the country. “We have instructed our employees in the field to immediately activate our Operation Centers in the areas affected by floods, typhoons, and other emergencies and to open their hotlines to fast-track coordination with our relief institutions. “We are in the holiday season now, but our office is always open to address the needs of our fellow citizens. Included in our service is the readiness to respond at any time of need,” he said. NFA has intensified its palay buying strategies under the Price Range Scheme to meet the rice relief requests of the Department of Social Welfare and Development, the Local Government Units and the Legislators for distribution to the affected families and individuals in calamity stricken areas. The agency has accomplished 95 percent of its buffer stocking target this year. The current buffer stock is now 5.661 million bags of equivalent milled rice. Lacson issued a standing order to its ranks to closely and continuously coordinate with the local farmers and the chief executives in their area for immediate response.Police breath testing in Maraenui, Napier ahead of gang tangi for 'Heil Dogg'
Supersub Jonsdottir scores 4 for Wolfsburg
Callum O’Hare and Tyrese Campbell gave the Blades a two-goal advantage at half-time, while Jesurun Rak-Sakyi ensured the final half an hour was played with far less intensity when he grabbed the Blades third. The victory sent the Blades to the top of the Sky Bet Championship table, but left the U’s suffering three defeats on the bounce. United head coach Buckingham said: “It’s a tough place to come, a team that are top of the table. “I thought we gave a good account of ourselves across, until we gave away a throw-in goal. “When you come to a place where teams haven’t scored in nine hours here, they don’t give up goals lightly. “We then had to go chase the game, but we’ve reverted back to the shape that we’re comfortable in, and we’ve done as much as we can to prevent them, but their ambition I’m sure as a club this year is to go up. Ours is to make sure we stay up. “We need to make sure we bring players back and we revert back to what we’re good at, and that we get ourselves right for what’s coming in the next month. “We spoke about how important this squad has been. The reality is we haven’t had this squad available to us for the last six to eight weeks. “We have to utilise the squad, whether it’s to get minutes into them and prepare for what’s coming, and it’s difficult to do because you’re coming up against very good players. “There were three of their players on the pitch that cost the entire amount of our team, so that’s the reality of what it is. “We’ve spoken about how important every player is going to be for us to achieve our goals this year, which are very different to their goals. “It’s about making sure we put ourselves in the best place for what’s to come. “We’ve got Millwall now on Saturday, we’ve got players back, and we’ve got a good run of games coming up where we can really go back to where we were at the start of the season.” Buckingham added: “I’ll take responsibility for results. This level is very different to what we’ve been used to. “We’re probably going to get more results against us than we’ve had in many a season, but I’ll accept that as long as players continue to try to showcase what they can do within the formation and the set-up we have. “It won’t work every time, but whether it’s belief or confidence within the group, as long as we continue to see that, we’ll always own the result and own the performance. “Players know their roles. It’s now about doing them as well as we can. If they do that, they’ll put themselves in the best place.”